Home - Products - Cell Cycle/DNA Damage - ROCK - CID-5056270

CID-5056270

CAS No. 681173-76-2

CID-5056270( —— )

Catalog No. M33971 CAS No. 681173-76-2

CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	446	In Stock
5MG	440	In Stock
10MG	613	In Stock
25MG	905	In Stock
50MG	1209	In Stock
100MG	1609	In Stock
200MG	2167	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CID-5056270
Note

Research use only, not for human use.
Brief Description

CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer.
Description

CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer. It can be used to study hypertension, Alzheimer's disease and arteriosclerosis.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

ROCK
Recptor

ROCK
Research Area

——
Indication

——

Chemical Information

CAS Number

681173-76-2
Formula Weight

339.37
Molecular Formula

C17H13N3O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

N(C(=O)C1OC=2C(OC1)=CC=CC2)C3=NC(=CS3)C=4C=CN=CC4
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Thiazovivin

Thiazovivin (Tzv) is a novel ROCK inhibitor with IC50 of 0.5 μM, promotes hESC survival after single-cell dissociation.
SAR407899 hydrochlor...

SAR407899 hydrochloride is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.
Cintirorgon

Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.

Sign In Join Free